Advertisement

Table of Contents

May 09, 2019; 133 (19)

BLOOD COMMENTARIES

PLENARY PAPER

  • Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3
    Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3
    Robert A. Campbell, Hansjorg Schwertz, Eugenio D. Hottz, Jesse W. Rowley, Bhanu Kanth Manne, A. Valance Washington, Robert Hunter-Mellado, Neal D. Tolley, Miles Christensen, Alicia S. Eustes, Emilie Montenont, Seema Bhatlekar, Cassandra H. Ventrone, Beth D. Kirkpatrick, Kristen K. Pierce, Stephen S. Whitehead, Sean A. Diehl, Paul F. Bray, Guy A. Zimmerman, Yasuhiro Kosaka, Patricia T. Bozza, Fernando A. Bozza, Andrew S. Weyrich and Matthew T. Rondina

BLOOD SPOTLIGHT

CLINICAL TRIALS AND OBSERVATIONS

  • Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
    Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
    John C. Byrd, Peter Hillmen, Susan O’Brien, Jacqueline C. Barrientos, Nishitha M. Reddy, Steven Coutre, Constantine S. Tam, Stephen P. Mulligan, Ulrich Jaeger, Paul M. Barr, Richard R. Furman, Thomas J. Kipps, Patrick Thornton, Carol Moreno, Marco Montillo, John M. Pagel, Jan A. Burger, Jennifer A. Woyach, Sandra Dai, Remus Vezan, Danelle F. James and Jennifer R. Brown

HEMATOPOIESIS AND STEM CELLS

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

THROMBOSIS AND HEMOSTASIS

LETTERS TO BLOOD

BLOOD WORK